BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Peng T. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Front Pharmacol 2021;12:660710. [PMID: 34017257 DOI: 10.3389/fphar.2021.660710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chan SW, Shafi T, Ford RC. Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step. Viruses 2021;13:2306. [PMID: 34835112 DOI: 10.3390/v13112306] [Reference Citation Analysis]
2 Faisthalab R, Suppiah S, Dorsey M, Sullivan KE, Icenogle J, Perelygina L. Drug Sensitivity of Vaccine-Derived Rubella Viruses and Quasispecies Evolution in Granulomatous Lesions of Two Ataxia-Telangiectasia Patients Treated with Nitazoxanide. Pathogens 2022;11:338. [DOI: 10.3390/pathogens11030338] [Reference Citation Analysis]
3 Akbar SM, Mahtab MA, Aguilar JC, Uddin MH, Khan MSI, Yoshida O, Penton E, Gerardo GN, Hiasa Y. Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection. Euroasian J Hepatogastroenterol 2021;11:27-31. [PMID: 34316461 DOI: 10.5005/jp-journals-10018-1341] [Reference Citation Analysis]
4 Kunstek H, Vreken F, Keita A, Hamblin MR, Dumarçay F, Varbanov M. Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light. Pharmaceuticals 2022;15:858. [DOI: 10.3390/ph15070858] [Reference Citation Analysis]